Article
Potent antitumor activity of cepharanthine against triple‑negative breast cancer spheroids compared with tetrandrine
6 Oct 2020
Abstract excerpt
Cepharanthine (CEP) is a bis‑bynzelisoquinoline alkaloid from the same class as the anticancer agent tetrandrine (TET). However, the effects of CEP against breast cancer have not been extensively studied, despite its long therapeutic history with low toxicity against other types of cancer. 3D culture systems more accurately mimic the human body and address the limitations of determining drug effectiveness...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
